Takeover Defenses

Shareholder Rights Plan

Shareholder Rights Plan

Quick Facts

  • Common name: Poison pill
  • Purpose: Defensive mechanism against hostile takeovers
  • Trigger: Typically 15-20% ownership threshold
  • Duration: Usually 1-3 years with renewal options
  • Legal status: Upheld by Delaware courts (1985)

A shareholder rights plan (commonly called a "poison pill") is a defensive mechanism that allows existing shareholders to purchase additional shares at a discount if any single shareholder acquires more than a specified percentage of the company's stock. It's the most common and effective hostile takeover defense.

In Plain English

A shareholder rights plan makes hostile takeovers prohibitively expensive. If an unwanted acquirer crosses the ownership threshold (usually 15-20%), every other shareholder gets the right to buy shares at half price. This massively dilutes the hostile bidder's stake, making the takeover economically impossible without board approval.

How It Works

The Mechanics

  1. Board adopts plan: Rights issued to all shareholders
  2. Rights attached to shares: Trade along with common stock
  3. Trigger threshold set: Usually 15-20% ownership
  4. Hostile acquirer crosses threshold: Rights become exercisable
  5. Flip-in feature activates: All shareholders except the acquirer can buy shares at 50% discount
  6. Acquirer's stake diluted: Takeover becomes uneconomic

Flip-In vs. Flip-Over

Flip-In Right:

  • Shareholders can buy target's shares at discount
  • Dilutes acquirer's stake in target
  • Most common feature

Flip-Over Right:

  • If target is merged into acquirer
  • Shareholders can buy acquirer's shares at discount
  • Protects against back-end squeeze-out

Typical Terms

FeatureStandard Provision
Trigger threshold15-20%
Discount50% of market price
Duration1-3 years (renewable)
Redemption priceNominal ($0.001 per right)
Board discretionCan waive for friendly deals
Shareholder voteTypically not required

Types of Pills

Traditional Poison Pill

  • Standard trigger (15-20%)
  • Designed for hostile takeover defense
  • Duration: 1-3 years

Low-Trigger Pill (COVID Pills)

  • Lower threshold (5-10%)
  • Deployed during market volatility
  • Prevents opportunistic accumulation
  • Gained popularity in 2020

Net Operating Loss (NOL) Pill

  • Very low trigger (4.9%)
  • Protects tax assets
  • Prevents ownership change under IRC Section 382
  • Courts more accepting of lower threshold

Dead Hand / Slow Hand Pills

  • Only continuing directors can redeem
  • Limits new board's ability to remove
  • Highly controversial
  • Struck down in some jurisdictions

Famous Shareholder Rights Plans

Netflix (2012)

When Carl Icahn accumulated a 10% stake, Netflix adopted a pill with a 10% trigger to prevent further accumulation without board engagement.

Twitter (2022)

After Elon Musk disclosed a 9.2% stake, Twitter's board adopted a pill with a 15% trigger. Musk eventually negotiated with the board for the $54.20/share acquisition.

Airgas (2011)

Airgas maintained its poison pill for over a year despite Air Products' hostile bid and shareholder support for the deal—upheld by Delaware courts as valid board discretion.

Delaware Validation

Moran v. Household International (1985) established:

  • Boards can adopt pills without shareholder approval
  • Pills are valid exercise of business judgment
  • Part of directors' fiduciary duty toolkit

Continuing Judicial Support

Airgas (2011) confirmed:

  • Boards can "just say no" to hostile offers
  • Pills can be maintained even against shareholder wishes
  • Board's duty is to shareholders, not individual bidders

Limits on Pills

Courts have struck down:

  • "Dead hand" pills (only certain directors can redeem)
  • Pills adopted solely to entrench management
  • Pills with unreasonably low triggers (except NOL pills)

Strategic Considerations

For Target Boards

Benefits:

  • Forces negotiation with the board
  • Provides time to find alternatives
  • Protects against opportunistic bids
  • Can be removed for friendly deals

Drawbacks:

  • Institutional investors may oppose
  • Proxy advisors often recommend against
  • May suppress legitimate premium offers
  • Creates entrenchment perception

For Potential Acquirers

Pills don't make takeovers impossible—they force acquirers to:

  • Negotiate with the board
  • Launch proxy fight to replace directors
  • Wait for pill expiration
  • Make offers compelling enough that board removes pill

Institutional Investor Views

Many institutional investors oppose pills:

  • ISS: Generally recommends against unless short-term and justified
  • Glass Lewis: Similar opposition to long-term pills
  • BlackRock/Vanguard: Often vote against pill ratification

Companies increasingly submit pills to shareholder vote, and many are rejected.

"Shelf" Pills vs. Active Pills

Active Pill:

  • Currently in effect
  • Rights issued and ready to trigger

Shelf Pill:

  • Prepared but not adopted
  • Can be implemented quickly if threat emerges
  • Increasingly common approach

Most large companies have a shelf pill ready for rapid deployment.

Practical Takeaways

For target companies: Shareholder rights plans remain the most effective takeover defense. Keep a shelf pill ready. If adopted, expect institutional investor scrutiny—be prepared to explain the specific threat and limited duration.

For potential acquirers: Don't expect to bypass the board. A pill means you must either negotiate a friendly deal or wage a proxy fight to replace directors who will redeem the pill. Plan for a longer, more expensive process.